Back to UBS Group AG

BLTE
7 quarters

Position history for UBS Group AG's holdings in BELITE BIO INC

UBS Group AG holds 768,359 shares of BLTE (BELITE BIO INC), worth $122.5M as of 2026-Q1. The position was increased (+496.8% shares). BLTE represents 0.0% of UBS Group AG's portfolio.

Current Value

$122.5M

Current Shares

768,359

Total Value Change

+$122.5M

Total Shares Change

+768,231

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q1
Latest
Increased
768,359
+496.8%
$122.5M0.0%$167.88
49
2025-Q4
Increased
128,752
+1036.0%
$20.6M0.0%$160.82
46
2025-Q3
Increased
11,334
+380.7%
$838,7160.0%$73.00
40
2025-Q2
Increased
2,358
+327.9%
$136,0560.0%$59.04
24
2025-Q1
Decreased
551
-95.5%
$36,4870.0%$66.70
0
2024-Q4
Increased
12,207
+9436.7%
$770,2620.0%$61.97
40
2024-Q3
New
128
-
$6,0010.0%$46.55
24

Other major holders of BLTE: RTW INVESTMENTS, LP, MILLENNIUM MANAGEMENT LLC, Holocene Advisors, LP

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used